Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Macrotope
AddedFeb 18, 2024
UpdatedJun 18, 2026
Macrotope

Macrotope

Angel

Macrotope: Your partner in therapeutic antibody and vaccine discovery with expert protein antigen design.

HQ
Princeton, NJ, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize immunology, Macrotope specializes in protein antigen design and production to support therapeutic antibody and vaccine discovery. The company leverages its extensive IP portfolio and decades of experience in antigen production, protein folding, and biochemistry to offer cutting-edge solutions. Macrotope's core product, the MacroAntigen™ Platform, is designed to enhance the immune response, making it a crucial partner for organizations focused on developing innovative vaccines and antibodies.

Macrotope's team comprises leading experts in immunology and biochemistry, contributing to its reputation as a pioneer in antigen-centric approaches. The company has garnered attention from notable investors in the biotech sector, further validating its impact and potential. Key achievements include the successful integration of its MacroAntigen Vaccine (MAV™) technology into various therapeutic pipelines, significantly advancing the field of antibody discovery. Overall, Macrotope has made substantial contributions to immunological research and therapeutic development, positioning itself as a vital player in the biotech industry.

Macrotope - Similar Companies

Macromoltek logo

Macromoltek

macromoltek.com

Macrophage Therapeutics logo

Macrophage Therapeutics

macrophagetx.com

Proteinea logo

Proteinea

proteinea.com

Meditope Biosciences logo

Meditope Biosciences

meditope.com

Protillion Biosciences logo

Protillion Biosciences

protillion.com

MacroGenics logo

MacroGenics

macrogenics.com

BigHat Biosciences logo

BigHat Biosciences

bighatbio.com

OmniAb logo

OmniAb

omniab.com

Nabla Bio logo

Nabla Bio

nabla.bio

AI Proteins logo

AI Proteins

aiproteinstx.com

Global Bio logo

Global Bio

Impact Proteomics logo

Impact Proteomics

ImmuneID logo

ImmuneID

Abbomax logo

Abbomax

abbomax.com

Abpro logo

Abpro

Macrotope - Quick Facts

Who are Macrotope's competitors?

Companies similar to Macrotope include Macromoltek, Macrophage Therapeutics, Proteinea and Meditope Biosciences.

When was Macrotope founded?

Macrotope was founded in 2015.

Where is Macrotope's headquarters located?

Macrotope's headquarters is located in Princeton, NJ, US.

When was Macrotope's last funding round?

Macrotope's most recent funding round was for $300k (USD) in August 2023.

How much has Macrotope raised to-date?

As of Aug 18, 2023, Macrotope has raised a total of $500k (USD).

How many employees does Macrotope have?

Macrotope has 5 employees as of Feb 5, 2024.

Macrotope - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Licensing
  • Recurring
Customer
  • Enterprise
Main Product
  • Protein Design
Tags
  • API
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified